STOCK TITAN

Lexicon Pharmaceuticals, Inc. (LXRX) Revenue by Year

LXRX

Lexicon Pharmaceuticals, Inc. generated $49.8M in revenue in fiscal year 2025. This represents an increase of 60.2% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $41.5M in revenue. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Lexicon Pharmaceuticals, Inc. has filed alongside them.

FY2025 annual
Revenue $49.8M
YoY +60.2%
5Y CAGR +15.7%
10Y CAGR -9.1%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

LXRX Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Revenue$41.5M$49.8M+60.2%$31.1M+2481.5%$1.2M+766.2%$139K-53.4%$298K-98.8%$24.0M-92.5%$322.1M+409.5%$63.2M-31.1%$91.7M+15.7%$79.3M-39.0%$130.0M+468.9%$22.9M+928.5%$2.2M+104.0%$1.1M-41.1%$1.8M

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

LXRX Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Revenue$692K-97.6%$21.1M+1572.1%$5.5M-79.3%$14.2M+710.4%$28.9M+1652.6%$1.3M+11.7%$26.6M+3688.0%$1.8M+980.2%$1.6M+419.6%$1.1M+4608.3%$701K$162K+315.4%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Lexicon Pharmaceuticals, Inc. financials

Frequently Asked Questions

What was Lexicon Pharmaceuticals, Inc.'s revenue in fiscal year 2025?

Lexicon Pharmaceuticals, Inc. generated $49.8M in revenue in fiscal year 2025.

How fast is Lexicon Pharmaceuticals, Inc.'s revenue growing?

Lexicon Pharmaceuticals, Inc. (LXRX) revenue rose by 60.2% year over year, from $31.1M to $49.8M in fiscal year 2025.

What is Lexicon Pharmaceuticals, Inc.'s revenue over the last twelve months?

Lexicon Pharmaceuticals, Inc. (LXRX) reported $41.5M in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Across the 15 fiscal years this page covers, Lexicon Pharmaceuticals, Inc. (LXRX) revenue went from $1.8M in fiscal year 2011 to $49.8M in fiscal year 2025.

Lexicon Pharmaceuticals, Inc. (LXRX) reported $692K in revenue in Q2 2026. This represents a decrease of 97.6% from the same quarter a year earlier.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Lexicon Pharmaceuticals, Inc. (LXRX) reported on that line in every period on record.